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a b s t r a c t
Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) is a rare hereditary
ataxia, characterized by the triad of early-onset cerebellar ataxia, peripheral sensorimotor
neuropathy and lower limb spasticity. Although ARSACS is increasingly reported worldwide,
we present the ﬁrst Polish family with a comprehensive clinical and neuropsychological
assessment, harboring two novel mutations in the SACS gene. Our results demonstrate the
variability in cognitive and behavioral proﬁles in ARSACS, which is in line with other
heredodegenerative ataxias. One should be aware of ARSACS in cases of autosomally
recessive inherited ataxias without common mutations.
© 2017 Polish Neurological Society. Published by Elsevier Sp. z o.o. All rights reserved.
Available online at www.sciencedirect.com
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Autosomal recessive spastic ataxia of Charlevoix-Saguenay
(ARSACS) is an early-onset hereditary ataxia, caused by
mutations in the SACS gene. The disease was initially described
in Quebec, but since then there have been subsequent reports
on the prevalence of ARSACS worldwide [1,2]. The classic
phenotype includes the triad of early-onset cerebellar ataxia,* Corresponding author.
E-mail address: magdalena.krygier@gumed.edu.pl (M. Krygier).
http://dx.doi.org/10.1016/j.pjnns.2017.08.003
0028-3843/© 2017 Polish Neurological Society. Published by Elsevier Speripheral sensorimotor neuropathy and lower limb spasticity.
Atypical cases may present with adult onset ataxia, Charcot-
Marie-Tooth-like phenotype or isolated spasticity [3]. The
characteristic feature, albeit not obligatory, is an increased
demarcation of retinal nerve ﬁbers on Ocular Coherence
Tomography, recently described also in ARSACS carriers [4].
The literature regarding neuropsychological status in
ARSACS is very limited. Although intellectual impairment
and cognitive decline are regarded as occasional features,p. z o.o. All rights reserved.
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been reported [5,6]. Additionally, behavioral and psychiatric
manifestations characteristic for the cerebellar cognitive
affective syndrome (CCAS) were also recognized, indicating
that neuropsychiatric disturbances may be a part of the
clinical spectrum of the disease [6–8].
Here we present a description of, to our knowledge, the ﬁrst
Polish family with ARSACS, in which two novel SACS
mutations were identiﬁed.
2. Clinical characteristics
The proband is a 33-year-old woman, born to a non-
consanguineous couple from Northern Poland. She has ﬁve
siblings, of whom two sisters and one brother are also
presenting clinical features of early-onset ataxia. Neither
their parents nor other relatives were found to have any signs
of ataxia. At the time of clinical examination three affected
sisters and one affected brother were 47, 45, 33, and 30-years
old, respectively. They all manifested ﬁrst signs of cerebellar
ataxia in early childhood. In the teen years the features of gait
and limb ataxia were accompanied by dysarthria, spasticity in
the lower limbs and peripheral neuropathy. Clinical examina-
tion revealed severe peripheral neuropathy in the lower limbs,
including distal muscle weakness and atrophy, bilateral pes
cavus, loss of Achilles reﬂexes, and decreased tactile and
vibration senses, whereas in the upper limbs moderate
atrophy of the interosseous and thenar muscles and slightly
decreased tendon reﬂexes. The patients presented with ataxia,
which ranged from 15 to 23.5 scores in the Scale for the
Assessment and Rating of Ataxia (SARA) and spasticity in theTable 1 – Clinical characteristics of the four siblings with ARSA
Patient
no.
Sex Age Age
at oset
Disease
duration
(years)
Gait
(0–8)
Stance
(0–6)
Sitting
(0–4)
Speec
disturba
(0–6)
1 K 47 1.5 45 7 6 0 2 
2 K 45 4 41 6 6 0 3 
3 K 33 2 31 3 6 0 2 
4 M 30 5 25 4 4 0 3 
Patient
no.
SPRS
(0–52)
MAS
(lower
limbs)
Nystagmus Retinal nerve
ﬁber
hypertrophy
Tend
reﬂex
Knee A
1 30 1.5 + + + 
2 21 1 + + ++ 
3 19 1 + + + 
4 23 R = 1; L = 1.5 + + +++ 
SARA = Scale for the Assessment and Rating of Ataxia; SPRS = Spastic Par
Resonance Imaging; R = Right; L = Left.lower limbs, which ranged from 19 to 30 in the Spastic
Paraplegia Rating Scale (SPRS) (Table 1).
Magnetic Resonance Imaging (MRI) revealed severe atrophy
of the superior vermis and the cerebellar hemispheres.
Additionally, diffuse cortical atrophy, thinning of the corpus
callosum, linear T2-hypointensities in the pons, and atrophy
of the cervical spinal cord were observed in all affected siblings
(Fig. 1). Nerve conductions studies showed mixed pattern of
nerve injuries (demyelinating and axonal) with predominant
sensory ﬁbers involvement (virtually no responses in both
upper and lower extremities). Finally, all of the siblings
exhibited a characteristic for ARSACS thickening of nerve
ﬁber layer in the intermaculopapillar region on ocular
coherence tomography (Fig. 1).
Extended neuropsychological examination included
screening assessment of cognitive functioning and evaluation
of speciﬁc cognitive domains such as semantic memory, visual
confrontation naming, visuomotor coordination, visuospatial
skills, attention and concentration, verbal short-term memo-
ry, working memory, verbal and non-verbal learning ability,
executive functions (verbal ﬂuency, planning and cognitive
ﬂexibility) and dynamic praxis. Obtained results revealed that
all patients exhibited a signiﬁcant visuomotor coordination
impairment as well as slight deﬁcits in verbal short-term
memory and naming. Reduced test scores were also observed
in other particular cognitive domains but they varied between
subjects. Screening assessment of global cognitive status
suggested mild dementia in Patient no. 2, while Patient no. 1
exhibited mild cognitive impairment. Cognitive functions
were better preserved in Patients no. 3 and 4. Neither
individual reported severe depressive symptoms and there
was no history of psychiatric disorders (Table 2).CS.
SARA score
h
nce
Finger
chase
(0–4)
Nose-ﬁnger
test
(0–4)
Fast
alternating
hand
movements
(0–4)
Heel-shin
slide (0–4)
Total (0–40)
3 2 1.5 2 23.5
1 1 1 2 20
1 1 1 1 15
1.5 1 1.5 1 16
on
es
Babiński
sign
Additional
symptoms
MRI ﬁndings
nkle
 + Dysphagia, urinary
dysfunction,
impaired vibration
sense at ankles,
pes cavus
Cerebellar atrophy,
linear T2-hypointensities
in the pons, generalized
cortical atrophy, narrowing
of the corpus callosum,
atrophy of the cervical
spinal cord
 +
 +
 +
aplegia Rating Scale; MAS = Modiﬁed Ashworth Scale; MRI = Magnetic
Fig. 1 – Characteristic MRI and ophthalmological findings. Bilateral frontal and parietal atrophy is presented on coronal T2
images for Patient 1 at age 47 years (A) and for Patient 4 at age 30 years (B). Coronal T2 image for Patient 1 demonstrates
predominant superior vermis atrophy (C). Axial TIRM cross-sections show linear hipointensities in the pons for Patients 1 (D)
and 4 (E). Retinal fundus examination reveals increased demarcation of the nerve fibers close to the optic disk, due to a
retinal nerve fiber hypertrophy (Patient 4, F).
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After obtaining informed consent, next-generation sequenc-
ing was performed on the genomic DNA from 30-years old
proband, using TruSightOneTM Sequencing Panel Kit (Illumina,
San Diego, CA, USA), which targets coding sequence and splice
sites of 4813 loci associated with known human clinical
phenotypes. Sequencing data were analyzed as previously
described [9]. The following two novel variants in the SACS
gene were detected: p.Ser3268_Ile3269fs/c.9804_9805insC and
p.Asp4192Asn/c.12574 G > A (according to the cDNA sequence
NM_001278055.1). Both identiﬁed SACS variants have 0
frequency in all databases uses in this study, including in-
house collection of 1343 Polish subjects. Cosegregation
analysis by Sanger sequencing conﬁrmed the presence of
both alterations in all affected individuals, whereas two
healthy siblings and the mother carried one of the two
variants. The c.9804_9805insC (p.Ser3268_Ile3269fs) mutation
results in a frameshift and premature termination of the
predicted protein, which lacks 1140 amino acids. The
c.12574 G > A substitution in exon 8 leads to a change of
one amino acid (p.Asp4192Asn) and is predicted to bedeleterous by SIFT (score: <0.05; http://sift.jcvi.org/) and
PolyPhen-2 (score: 1.00; http://genetics.bwh.harvard.edu/
pph2/) softwares.
4. Discussion
Presented individuals are compound heterozygotes for the
novel frameshift and missense variant in the SACS gene. The
majority of SACS mutations outside of Quebec are private and
can be distributed throughout the whole gene. To date no clear
genotype-phenotype correlation has been identiﬁed [2]. The
range of clinical symptoms and the course of the disease in the
siblings is consistent with cases described in the literature and
there is little intra-familial phenotypic variability. The altera-
tions seen on brain MRI are, however, relatively severe in
comparison to other patients. Classic neuroimaging features
described in the French-Canadian population were limited to
the infratentorial region of the brain. Recent studies on the
German and Spanish cohorts revealed, however, a common
presence of supratentorial alterations in ARSACS, such as
bilateral parietal cerebral atrophy and thinning of the corpus
callosum [3,10]. In the presented family these features are also
Table 2 – Neuropsychological assessment.
Patient No. Patient No.
1 2 3 4 1 2 3 4
Screening assessment of global
cognitive status
Verbal learning
MMSE (max. 30) 26 21 29 30 RAVLT – learning
curie [intrusions]
5–7–8–9–11 [2] 3–5–8–7–8 [0] 6–12–13–14–14 [0] 7–9–10–11–12 [0]
Semantic memory RAVLT – corrected recognition*
[correct/false positive]
10 [11/1] 10 [10/0] 15 [15/0] 14 [14/0]
Information subtest
from WAIS (scaled score)
11 7 8 10 RAVLT – spontaneous recall
after 10 min delay [intrusions]
8 [1] 7 [1] 13 [0] 13 [0]
Word retrieval % Of information recalled
after delay
73 88 93 108
BNT (max. 60) 52 34 52 48 RAVLT – corrected
delayed recognition*
10 [11/1] 11 [14/3] 13 [14/1] 14 [15/1]
Visuomotor coordination Nonverbal learning
SDMT (scaled score) 3 4 4 3 RCFT 3 min immediate
recall (max. 36) (T score)
39 28 51 69
Visuospatial function RCFT 30 min delayed
recall (max. 36), (T score)
36 26 47 64
Object perception Verbal ﬂuency
VOSP Shape Detection (max. 20) 20 20 20 19 Semantic – animals/fruits 17/10 9/12 20/16 16/7
VOSP Incomplete Letters (max. 20) 19 16 19 20 Phonemic – ‘‘K’’/‘‘P’’/‘‘M’’ 6/14/9 9/3/7 11/14/14 10/5/6
Space perception Cognitive ﬂexibility
VOSP Dot counting (max. 10) 9 10 10 10 The Brixton Spatial Anticipation 6 6 7 7
VOSP Position Discrimination
(max. 20)
20 15 20 20 Test (scaled score)
VOSP Number Location (max. 10) 9 10 9 8 Planning
VOSP Cube Analysis (max. 10) 9 10 10 10 TOLDX-2 – total move score
(standard score)
96 70 106 120
Constructional praxis TOLDX-2 – total correct score
(standard score)
94 88 96 114
RCFT copy (max. 36) (T score) 33 33 36 35 Dynamic praxis
Attention and concentration 10 7 14 13 Motor sequence learning task
Serial 7 subtraction (max. 14) (6 min 14 s) (6 min 42 s) (67 s) (57 s) 1st sequence (max. 5) 0 2 4 5
Verbal short-term memory 2nd sequence (max. 5) 0 0 5 5
Digit span – forward 4 3 4 4 Mood
Working memory BDI 6 7 4 9
Digit span – forward vs. backwards 4/3 3/2 4/3 4/3
TMT A vs. TMT B
(T scores) [errors]
72 [0]/58 [1] 81 [0]/68 [3] 65 [0]/66 [3] 46 [0]/49 [0]
MMSE = Mini-Mental State Examination; WAIS = The Wechsler Adult Intelligence Scale; BNT = Boston Naming Test; SDMT = Symbol Digit Modalities Test; VOSP = Visual Object and Space Perception
Battery; TMT = Trail Making Test; RAVLT = The Rey Auditory Verbal Learning Test, *corrected recognition score = correct recognitions minus false positive recognitions; RCFT = Rey Complex Figure Test
and Recognition Trial; TOLDX-2 = Tower of London-Drexel University - 2nd Edition; BDI = Beck Depression Inventory; scores highlighted in bold indicate impairment.
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parietal but also in the frontal lobes.
On neuropsychological examination all individuals pre-
sented a signiﬁcant visuomotor coordination impairment and
slight deﬁcits in verbal short-term memory and visual
confrontation naming. In other areas we did not observe a
common pattern of dysfunction. The presence of mild
cognitive impairment in Patient no. 1 and mild dementia in
Patient no. 2 may suggest that cognitive functions deteriorate
along with the disease duration, which was 45 and 41 years,
respectively. Interestingly, the siblings exhibited no signiﬁcant
deﬁcits in object and space perception, as well as construc-
tional praxis. Additionally, there was no history of neuropsy-
chiatric symptoms, commonly reported in patients with
lesions involving the limbic cerebellum. However, it should
be emphasized that ARSACS is a complex neurodegenerative
disorder, thus the presence of such symptoms in previously
described cases may result from of the various involvement of
supra- and infratentorial structures. To our knowledge in our
group the neuropsychological assessment was the most
complex when compared to other studies.
Our results indicate that screening for SACS mutations
should be considered in patients with autosomally recessive
inherited cerebellar ataxia and no common mutations
detected. Additionally, neuropsychological proﬁles of the
presented cases demonstrate the diversity in cognitive and
behavioral phenotypes in ARSACS, as it is seen in other
heredodegenerative ataxias and the proﬁle is not helpful in
establishing the diagnosis. On the other hand, Ocular Coher-
ence Tomography might be helpful in differential diagnosis.
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